Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.89	24.59	25.07
Graham Fair Price	599.34	200187.77	28625.40
PEG	-99.96	< 0.005	1.29
Price/Book	-10.81	0.47	0.53
Price/Cash Flow	-54.30	27.84	60.92
Prices/Earnings	-98.01	2.63	-132.13
Price/Sales	-30.58	2.13	3.07
Price/FCF	-54.30	27.84	60.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	30.76	0.21	0.16
Operating Margin	14.02	0.12	0.10
ROA	3404.64	0.02	< 0.005
ROE	< 0.005	0.05	4380.25
ROIC	0.02	0.02	-25.47
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.37	0.04	766.41
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.50	0.53	5.13
EPS QOQ	-1.03	52.36	4994.18
FCF QOQ	-0.65	1.04	60.42
Revenue QOQ	-0.06	0.34	425.26
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	286.41	271.49	-5.21
Days Sales Outstanding (DSO)	86.65	84.60	-2.36
Inventory Turnover	0.31	0.33	5.50
Debt/Capitalization	0.28	0.34	20.45
Quick Ratio	2.53	1.67	-33.84
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	190201.75	198723.51	4.48
Cash	81882.86	99098.68	21.02
Capex	-1309.69	-3927.53	-199.88
Free Cash Flow	1661.27	3387.23	103.89
Revenue	32999.49	44297.37	34.24
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.54	3.00	-33.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.85	6.08	113.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating